Assenagon Asset Management S.A. Lowers Holdings in Oscar Health, Inc. (NYSE:OSCR)

Assenagon Asset Management S.A. lowered its position in Oscar Health, Inc. (NYSE:OSCR) by 55.6% in the fourth quarter, Holdings Channel reports. The fund owned 432,714 shares of the company’s stock after selling 541,077 shares during the period. Assenagon Asset Management S.A.’s holdings in Oscar Health were worth $5,816,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in OSCR. Point72 Hong Kong Ltd purchased a new position in Oscar Health in the second quarter worth approximately $78,000. KBC Group NV lifted its stake in Oscar Health by 41.2% in the third quarter. KBC Group NV now owns 4,552 shares of the company’s stock worth $97,000 after acquiring an additional 1,328 shares during the last quarter. ORG Wealth Partners LLC purchased a new position in Oscar Health in the fourth quarter worth approximately $100,000. Amalgamated Bank lifted its stake in Oscar Health by 27.7% in the second quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after acquiring an additional 1,458 shares during the last quarter. Finally, Optimum Investment Advisors acquired a new stake in Oscar Health during the third quarter worth approximately $142,000. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Oscar Health Stock Up 6.5 %

OSCR stock opened at $15.92 on Tuesday. The company has a fifty day moving average price of $15.03 and a 200 day moving average price of $16.83. Oscar Health, Inc. has a 12 month low of $10.45 and a 12 month high of $23.79. The company has a market cap of $3.94 billion, a price-to-earnings ratio of -265.26, a price-to-earnings-growth ratio of 0.57 and a beta of 1.70. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The business had revenue of $2.42 billion during the quarter, compared to analysts’ expectations of $2.33 billion. During the same quarter last year, the company earned ($0.29) EPS. The firm’s revenue for the quarter was up 68.3% compared to the same quarter last year. Sell-side analysts expect that Oscar Health, Inc. will post -0.01 earnings per share for the current year.

Insider Activity at Oscar Health

In other Oscar Health news, CAO Victoria Baltrus sold 8,078 shares of the company’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total transaction of $146,050.24. Following the completion of the transaction, the chief accounting officer now owns 146,036 shares in the company, valued at approximately $2,640,330.88. This represents a 5.24 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Vice Chairman Joshua Kushner acquired 276,040 shares of the business’s stock in a transaction on Monday, November 11th. The shares were purchased at an average price of $13.58 per share, with a total value of $3,748,623.20. Following the transaction, the insider now owns 5,031,262 shares in the company, valued at $68,324,537.96. The trade was a 5.80 % increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders acquired 1,055,478 shares of company stock worth $14,432,852 and sold 103,610 shares worth $1,847,519. 25.11% of the stock is owned by insiders.

Analysts Set New Price Targets

OSCR has been the subject of several research analyst reports. Bank of America cut shares of Oscar Health from a “neutral” rating to an “underperform” rating and lowered their target price for the company from $21.00 to $13.50 in a report on Wednesday, November 6th. UBS Group initiated coverage on shares of Oscar Health in a report on Monday, October 7th. They issued a “neutral” rating and a $23.00 target price for the company. Finally, Jefferies Financial Group initiated coverage on shares of Oscar Health in a report on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 target price for the company. Two analysts have rated the stock with a sell rating, two have given a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $21.56.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.